Cargando…
Evolving measles status and immunization policy development in six European countries
Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifti...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009904/ https://www.ncbi.nlm.nih.gov/pubmed/35180372 http://dx.doi.org/10.1080/21645515.2022.2031776 |
_version_ | 1784687364366401536 |
---|---|
author | Vojtek, Ivo Larson, Heidi Plotkin, Stanley Van Damme, Pierre |
author_facet | Vojtek, Ivo Larson, Heidi Plotkin, Stanley Van Damme, Pierre |
author_sort | Vojtek, Ivo |
collection | PubMed |
description | Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifting measles epidemiology in six European countries (Italy, Belgium, Germany, Romania, UK, and Ukraine); where policies and strategies have evolved in response to country-specific disease and vaccination patterns. Periodic outbreaks have occurred in all countries against a background of declining measles-containing-vaccine (MCV) uptake and increasing public vaccine hesitancy (with substantial regional or social differences in measles burden and vaccine uptake). Health-care worker (HCW) vaccine skepticism is also seen. While many outbreaks arise or involve specific susceptible populations (e.g., minority/migrant communities), the broader pattern is spread to the wider (and generally older) population; often among incompletely/non-vaccinated individuals as a legacy of previous low uptake. Immunization policy and strategic responses are influenced by political and social factors, where public mistrust contributes to vaccine hesitancy. A strong centralized immunization framework (allied with effective regional implementation and coherent political commitment) can effectively increase uptake. Mandatory vaccination has increased childhood MCV uptake in Italy, and similar benefits could be anticipated for other countries considering vaccine mandates. Although possible elsewhere, socio-political considerations render mandating impractical in other countries, where targeted immunization activities to bolster routine uptake are more important. Addressing HCW skepticism, knowledge gaps, improving access and increasing public/community engagement and education to address vaccine hesitancy/mistrust (especially in communities with specific unmet needs) is critical. |
format | Online Article Text |
id | pubmed-9009904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-90099042022-04-15 Evolving measles status and immunization policy development in six European countries Vojtek, Ivo Larson, Heidi Plotkin, Stanley Van Damme, Pierre Hum Vaccin Immunother Licensed Vaccines – Research Paper Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifting measles epidemiology in six European countries (Italy, Belgium, Germany, Romania, UK, and Ukraine); where policies and strategies have evolved in response to country-specific disease and vaccination patterns. Periodic outbreaks have occurred in all countries against a background of declining measles-containing-vaccine (MCV) uptake and increasing public vaccine hesitancy (with substantial regional or social differences in measles burden and vaccine uptake). Health-care worker (HCW) vaccine skepticism is also seen. While many outbreaks arise or involve specific susceptible populations (e.g., minority/migrant communities), the broader pattern is spread to the wider (and generally older) population; often among incompletely/non-vaccinated individuals as a legacy of previous low uptake. Immunization policy and strategic responses are influenced by political and social factors, where public mistrust contributes to vaccine hesitancy. A strong centralized immunization framework (allied with effective regional implementation and coherent political commitment) can effectively increase uptake. Mandatory vaccination has increased childhood MCV uptake in Italy, and similar benefits could be anticipated for other countries considering vaccine mandates. Although possible elsewhere, socio-political considerations render mandating impractical in other countries, where targeted immunization activities to bolster routine uptake are more important. Addressing HCW skepticism, knowledge gaps, improving access and increasing public/community engagement and education to address vaccine hesitancy/mistrust (especially in communities with specific unmet needs) is critical. Taylor & Francis 2022-02-18 /pmc/articles/PMC9009904/ /pubmed/35180372 http://dx.doi.org/10.1080/21645515.2022.2031776 Text en © 2022 GlaxoSmithKline Biologicals S.A. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Licensed Vaccines – Research Paper Vojtek, Ivo Larson, Heidi Plotkin, Stanley Van Damme, Pierre Evolving measles status and immunization policy development in six European countries |
title | Evolving measles status and immunization policy development in six European countries |
title_full | Evolving measles status and immunization policy development in six European countries |
title_fullStr | Evolving measles status and immunization policy development in six European countries |
title_full_unstemmed | Evolving measles status and immunization policy development in six European countries |
title_short | Evolving measles status and immunization policy development in six European countries |
title_sort | evolving measles status and immunization policy development in six european countries |
topic | Licensed Vaccines – Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009904/ https://www.ncbi.nlm.nih.gov/pubmed/35180372 http://dx.doi.org/10.1080/21645515.2022.2031776 |
work_keys_str_mv | AT vojtekivo evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries AT larsonheidi evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries AT plotkinstanley evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries AT vandammepierre evolvingmeaslesstatusandimmunizationpolicydevelopmentinsixeuropeancountries |